For the third consecutive year, LABRHA organised last 15th and 16th of September in Lyon, a new edition of the LABRHA European Board on Viscosupplementation. For this 3rd edition, the task group counted 10 experts from different European countries (EUROVISCO Group). 2 new members joined the team: Dr. Jordi Monfort, Read more…
Addition of Mannitol to Hyaluronic Acid may Shorten Viscosupplementation Onset of Action in Patients with Knee Osteoarthritis: Post-Hoc Analysis of A Double-blind, Controlled Trial. Eymard F, Bossert M, Lecurieux R, Maillet B, Chevalier X, et al. (2016) J Clin Exp Orthop 2: 21. doi: 10.4172/2471-8416.100021 OBJECTIVE: To compare the speed Read more…
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol. T. Conrozier, AM. Bozgan, M. Bossert, M. Sondag, A. Lohse-Walliser and JC. Balblanc.Clin Med Insights Arthritis Musculoskelet Disord. 2016 Sep 25;9:175-9. doi: 10.4137/CMAMD.S39432 . The above Read more…
Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis. Results of a double-blind, controlled, multicenter, randomized trial. T. Conrozier, F. Eymard, N. Afif, JC. Balblanc, V. Legré-Boyer, X. Chevalier, on behalf of the Happyvisc Study. The Knee. 2016. Read more…
LABRHA participated in the 17th EULAR Congress which took place from the 8th to the 11th of June 2016 in London. 1) Predictive factors of failure of viscosupplementation in patients with knee Osteoarthritis. Results of a post-hoc analysis of a double blind, controlled non Inferiority trial. F. Eymard, T. Conrozier, Read more…